Join        Login             Stock Quote

Medtronic (MDT) 3Q Profit Tops Street, Reiterates Forecast

 February 19, 2013 07:43 AM

(By Balachander) Medtronic Inc. (NYSE: MDT) reported a rise quarterly earnings, beating Wall Street expectations, helped by growth in emerging markets and product launches.

On a non-GAAP basis, earnings per share (EPS) increased 11 percent to 93 cents, beating analysts' expectations of 91 cents. Reported earnings grew 6 percent to $988 million.

Revenue rose 4 percent to $4.03 billion on a constant currency basis, coming in in line with consensus estimate for the third quarter ended Jan. 25.

Medtronic said several businesses and regions contributed to the company's steady growth in the quarter.

[Related -Medtronic, Inc. (MDT): Turning The Beat Around?]

Emerging market revenue jumped 21 percent, while international revenue advanced 7 percent on a constant currency basis.

Segment wise, sales from the company's Cardiac and Vascular group and the Restorative Therapies group rose 5 percent and 3 percent, respectively.

Sales from implantable cardioverter defibrillators (ICDs) fell 2 percent while Pacing sales were flat. Spine revenue declined 3 percent.

Drug-eluting stent revenue surged 42 percent because of "significant" share gains of the Resolute Integrity drug-eluting stent in Japan and strong performances in the U.S. and other markets, the company said.

Looking ahead for fiscal 2013, the company still expects EPS in the range of $3.66 to $3.70, on revenue growth between 3 percent and 4 percent.

Analysts expect EPS of $3.68 on revenue growth of 2 percent.

MDT ended Friday's regular trading at $47.12. The stock has been trading in the 52-week range of $35.67 to $47.40.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageEmerging-Markets Stocks Took The Lead Last Week

Emerging-markets equities enjoyed a solid rise last week among the major asset classes, based on a set of read on...

article imageDoes Your Latest Investment Pass This Test?

On Wednesday, I sounded the alarm about the problems looming for some consumer staples stocks. In short, read on...

article imageIs The Slump In US Manufacturing Easing?

Yesterday’s November survey data from the Philadelphia Fed hints at the possibility that a stronger trend read on...

article imageMarket Potentially Facing Near Term Technical Headwinds

After the S&P 500 Index pullback on Thursday and Friday last week, the market's advance on Monday and read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.